Mirum’s Rare Liver Disease Drug Meets Main Goal in Mid-stage Study

by | May 4, 2026 | Health

Spread the love
Mirum Pharmaceuticals said on Monday its experimental drug, volixibat, met the main ⁠goal of a mid-stage study by reducing severe itching or pruritus in patients with ⁠a…
Reuters Health Information

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments